In mice, GKT137831 ameliorated hypertensive cardiac remodeling [41], doxorubicin-induced cardiotoxicity [42], acute lung injury [27], acute kidney injury [43], and type I diabetes vascular dysfunction [44], the effects of which were attributed to inhibition of NOX1/4-driven ROS production in vivo. This evidence concerns the gene NOX1 and injury.